South Korea's cancer immunotherapy market is projected to register a CAGR of 7.89% through 2033, fueled by breakthroughs in immune system research, the escalating burden of cancer, and increasing reliance on personalized medicine through biomarker-based treatment strategies. https://www.imarcgroup.com/south-korea-cancer-immunotherapy-market